---
title: "Lasofoxifene - Postmenopausal osteoporosis"
sidebar: mydoc_sidebar
permalink: db06202-mesh-d015663-1.html
toc: false 
---


Path ID: `DB06202_MESH_D015663_1`
{% include image.html url="images/db06202-mesh-d015663-1.png" file="db06202-mesh-d015663-1.png" alt="db06202-mesh-d015663-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C111332 | lasofoxifene | Drug |
| UniProt:P03372 | Estrogen receptor alpha | Protein |
| UniProt:Q92731 | Estrogen receptor beta | Protein |
| GO:0043627 | Response to estrogen | BiologicalProcess |
| CL:0000092 | Osteoclast | Cell |
| GO:0046849 | Bone remodeling | BiologicalProcess |
| GO:0045453 | Bone resorption | BiologicalProcess |
| MESH:D015663 | Postmenopausal osteoporosis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Lasofoxifene | INCREASES ACTIVITY OF | Estrogen Receptor Alpha |
| Lasofoxifene | INCREASES ACTIVITY OF | Estrogen Receptor Beta |
| Estrogen Receptor Alpha | PARTICIPATES IN | Response To Estrogen |
| Estrogen Receptor Beta | PARTICIPATES IN | Response To Estrogen |
| Response To Estrogen | NEGATIVELY REGULATES | Osteoclast |
| Response To Estrogen | NEGATIVELY REGULATES | Bone Remodeling |
| Osteoclast | CONTRIBUTES TO | Bone Resorption |
| Bone Remodeling | CONTRIBUTES TO | Postmenopausal Osteoporosis |
| Bone Resorption | CAUSES | Postmenopausal Osteoporosis |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB06202](https://go.drugbank.com/drugs/DB06202)
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817938/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817938/)

Reference: 
  - [https://go.drugbank.com/drugs/DB06202](https://go.drugbank.com/drugs/DB06202)
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817938/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817938/)
